A carregar...
Recent Advances in the Pharmacology of Tardive Dyskinesia
Tardive dyskinesia (TD) is a syndrome of abnormal involuntary movements that follows treatment with dopamine D2-receptor antagonists. Recent approval of vesicular monoamine transporter-2 (VMAT2) inhibitors offers hope for reducing the impact of TD. Although these drugs represent a significant advanc...
Na minha lista:
| Publicado no: | Clin Psychopharmacol Neurosci |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean College of Neuropsychopharmacology
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7609206/ https://ncbi.nlm.nih.gov/pubmed/33124584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.4.493 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|